These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 403757)

  • 1. Cellular and humoral immunity in non-Hodgkin's lymphoma: correlation of immunodeficiencies with clinicopathologic factors.
    Lapes M; Rosenzweig M; Barbieri B; Joseph RR; Smalley RV
    Am J Clin Pathol; 1977 Apr; 67(4):347-50. PubMed ID: 403757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune function of successfully treated lymphoma patients.
    King GW; Yanes B; Hurtubise PE; Balcerzak SP; LoBuglio AF
    J Clin Invest; 1976 Jun; 57(6):1451-60. PubMed ID: 932190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoantigen response in patients successfully treated for lymphoma. A Southwest Oncology Group study.
    King GW; Grozea PC; Eyre HJ; LoBuglio AF
    Ann Intern Med; 1979 Jun; 90(6):892-5. PubMed ID: 375792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prednisone treatment on the human immune response to keyhole limpet hemocyanin.
    Tuchinda M; Newcomb RW; DeVald BL
    Int Arch Allergy Appl Immunol; 1972; 42(4):533-44. PubMed ID: 4624020
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-keyhole limpet hemocyanin antibody in normal unsensitized individuals.
    Burke GP; Smith KA; Stocking RI; Ferm M; McIntyre OR
    J Allergy Clin Immunol; 1977 Apr; 59(4):309-13. PubMed ID: 850020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune dysfunction in non-Hodgkin's lymphoma.
    Advani SH; Dinshaw KA; Nair CN; Gopal R; Talwalkar GV; Iyyer YS; Bhatia HM; Desai PB
    Cancer; 1980 Jun; 45(11):2843-8. PubMed ID: 7379014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral and cell-mediated immune response in patients with malignant melanoma. I. In vitro lymphocyte reactivity to PHA and antigens following immunization.
    de Gast GC; The TH; Schraffordt Koops H; Huiges HA; Oldhoff J; Nieweg HO
    Cancer; 1975 Oct; 36(4):1289-97. PubMed ID: 1175127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39.
    Foy TM; Shepherd DM; Durie FH; Aruffo A; Ledbetter JA; Noelle RJ
    J Exp Med; 1993 Nov; 178(5):1567-75. PubMed ID: 7693850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary immunodeficiencies.
    Bull World Health Organ; 1971; 45(1):125-42. PubMed ID: 5004396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of serum total IgE and cell-mediated immunity in patients with Hodgkin's disease.
    Rubinstein E; Sokal JE; Reisman RE; Arbesman CE
    Int Arch Allergy Appl Immunol; 1977; 55(1-6):439-43. PubMed ID: 591107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological responsiveness against two primary antigens in untreated patients with Hodgkin's disease.
    Gast GC; Halie MR; Nieweg HO
    Eur J Cancer (1965); 1975 Apr; 11(4):217-24. PubMed ID: 1095376
    [No Abstract]   [Full Text] [Related]  

  • 14. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity.
    Campbell MJ; Esserman L; Byars NE; Allison AC; Levy R
    J Immunol; 1990 Aug; 145(3):1029-36. PubMed ID: 2373859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits.
    Campbell MJ; Carroll W; Kon S; Thielemans K; Rothbard JB; Levy S; Levy R
    J Immunol; 1987 Oct; 139(8):2825-33. PubMed ID: 3498771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma.
    Arvin AM; Pollard RB; Rasmussen LE; Merigan TC
    J Clin Invest; 1980 Apr; 65(4):869-78. PubMed ID: 6244336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elaboration of systemic immunity following inner ear immunization.
    Harris JP; Woolf NK; Ryan AF
    Am J Otolaryngol; 1985; 6(3):148-52. PubMed ID: 3874563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary immune defects in non-Hodgkin's lymphoma.
    Datta U; Kaur K; Varma SC; Bhaskar KV; Sehgal S
    Indian J Med Res; 1992 Apr; 96():91-5. PubMed ID: 1428071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to keyhole limpet hemocyanin and oral Actinomyces viscosus antigens in Macaca arctoides.
    Reed MJ; Borkow I; Staple PH
    J Periodontol; 1981 Mar; 52(3):111-8. PubMed ID: 6939831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant lymphomas of follicular center cell origin in man. I. Immunologic studies.
    Leech JH; Glick AD; Waldron JA; Flexner JM; Horn RG; Collins RD
    J Natl Cancer Inst; 1975 Jan; 54(1):11-21. PubMed ID: 1089792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.